Biotech Values

[DewDiligence]

ITMN cut its workforce 40% (and did not even bother to issue a PR). Here’s the 8K SEC filing: http://biz.yahoo.com/e/100526/itmn8-k.html .

The layoff does not necessarily signify the demise of ITMN-191 insofar as Roche rather than ITMN is supposedly doing the heavy lifting for this compound. On the other hand, the layoff does not exactly inspire confidence that ITMN-191 remains viable. I posted three months ago that I think ITMN-191 is dead for all practical purposes (#msg-46797334).